Natixis Advisors’s Sotera Health SHC Stock Holding History

Natixis Advisors’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$464K	Buy	+26,197	New	+$413K	﹤0.01%	1705
2022 Q3	–	Sell	-148,096	Closed	-$2.9M	–	1508
2022 Q2	$2.9M	Sell	148,096 -37,357	-20%	-$783K	0.01%	801
2022 Q1	$4.02M	Buy	185,453 +8,390	+5%	+$178K	0.02%	753
2021 Q4	$4.17M	Buy	177,063 +14,683	+9%	+$351K	0.02%	729
2021 Q3	$4.25M	Buy	162,380 +18,728	+13%	+$453K	0.02%	696
2021 Q2	$3.48M	Buy	+143,652	New	+$3.53M	0.02%	738

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Natixis Advisors's SHC Position: Q2 2026 in Review

Natixis Advisors opened a new position in Sotera Health (SHC) in Q2 2026: 26,197 shares worth $464K. The stake represents ﹤0.01% of the portfolio and ranks #1705 among its holdings. This is a return to the name: Natixis Advisors previously reported a position in SHC as recently as Q2 2022.

Natixis Advisors first reported a position in SHC in Q2 2021 and has held it in 6 quarters since. The position peaked at $4.25M in Q3 2021. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

Natixis Advisors held 26,197 shares of Sotera Health worth $464K as of Q2 2026.
Sotera Health was a new Natixis Advisors position in Q2 2026.
Sotera Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1705 holding.
Natixis Advisors first reported a position in Sotera Health in Q2 2021 and has held it in 6 quarters since.
Natixis Advisors's Sotera Health position peaked at $4.25M in Q3 2021.
320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.